Sudarkodi Alagarsamy

Statistics

Publications

Citations

332

H-Index

Active since

1992

Affiliations

The University of Texas Medical Branch at Galveston(Current)

Ferring Pharmaceuticals (Switzerland)

Sudarkodi Alagarsamy is an author at The University of Texas Medical Branch at Galveston specializing in pharmacology, receptor pharmacology, and neuroscience.

Publications per year

1992–2020

Publications

Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome

Diane M. Hargrove, Sudarkodi Alagarsamy, Glenn Croston et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 59 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

New, Potent, Selective, and Short-Acting Peptidic V<sub>1a</sub>Receptor Agonists

Kazimierz Wiśniewski, Robert Galyean, Hiroe Tariga et al. · Journal of Medicinal Chemistry · 2011 · 49 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Dopamine neurotoxicity in cortical neurons

Sudarkodi Alagarsamy, Melissa Phillips, Todd C. Pappas et al. · Drug and Alcohol Dependence · 1997 · 40 citations

Life Sciences, Neurobiology, Neuroscience +14

Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension

Régent Laporte, Arash Kohan, Joshua Heitzmann et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 39 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance

Kazimierz Wiśniewski, Javier Sueiras-Diaz, Guangcheng Jiang et al. · Journal of Medicinal Chemistry · 2016 · 39 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

1–5 of 10